13F HOLDINGS REPORT
ENAVATE SCIENCES GP, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001953107-26-000003
Total Value
$506.8M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ZENAS BIOPHARMA INC | ZBIO | 3,919,159 | $142.3M | 28.08% |
| 2 | IMMUNOME INC | IMNM | 4,768,583 | $102.4M | 20.21% |
| 3 | SIONNA THERAPEUTICS INC | SION | 2,478,030 | $101.9M | 20.12% |
| 4 | UPSTREAM BIO INC | UPB | 2,459,703 | $66.8M | 13.18% |
| 5 | COMPASS THERAPEUTICS INC | CMPX | 7,788,150 | $41.8M | 8.25% |
| 6 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 2,626,946 | $32.9M | 6.49% |
| 7 | CAMP4 THERAPEUTICS CORP | CAMP | 3,035,825 | $18.6M | 3.67% |